Vanguard Group’s Day One Biopharmaceuticals DAWN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $40.1M | Buy |
6,176,495
+233,252
| +4% | +$1.52M | ﹤0.01% | 2234 |
|
|
2025
Q1 | $47.1M | Buy |
5,943,243
+94,320
| +2% | +$748K | ﹤0.01% | 2111 |
|
|
2024
Q4 | $74.1M | Sell |
5,848,923
-38,287
| -0.7% | -$485K | ﹤0.01% | 1991 |
|
|
2024
Q3 | $82M | Buy |
5,887,210
+1,263,938
| +27% | +$17.6M | ﹤0.01% | 1970 |
|
|
2024
Q2 | $63.7M | Sell |
4,623,272
-151,211
| -3% | -$2.08M | ﹤0.01% | 2053 |
|
|
2024
Q1 | $78.9M | Buy |
4,774,483
+4,737
| +0.1% | +$78.3K | ﹤0.01% | 1976 |
|
|
2023
Q4 | $69.6M | Buy |
4,769,746
+139,992
| +3% | +$2.04M | ﹤0.01% | 2043 |
|
|
2023
Q3 | $56.8M | Buy |
4,629,754
+346,090
| +8% | +$4.25M | ﹤0.01% | 2070 |
|
|
2023
Q2 | $51.1M | Buy |
4,283,664
+1,151,683
| +37% | +$13.8M | ﹤0.01% | 2171 |
|
|
2023
Q1 | $41.9M | Buy |
3,131,981
+23,008
| +0.7% | +$308K | ﹤0.01% | 2254 |
|
|
2022
Q4 | $66.9M | Buy |
3,108,973
+493,532
| +19% | +$10.6M | ﹤0.01% | 2021 |
|
|
2022
Q3 | $52.4M | Sell |
2,615,441
-11,033
| -0.4% | -$221K | ﹤0.01% | 2160 |
|
|
2022
Q2 | $47M | Sell |
2,626,474
-359,952
| -12% | -$6.44M | ﹤0.01% | 2222 |
|
|
2022
Q1 | $29.6M | Sell |
2,986,426
-48,351
| -2% | -$480K | ﹤0.01% | 2569 |
|
|
2021
Q4 | $51.1M | Buy |
3,034,777
+2,214,704
| +270% | +$37.3M | ﹤0.01% | 2335 |
|
|
2021
Q3 | $19.5M | Buy |
820,073
+200,689
| +32% | +$4.76M | ﹤0.01% | 2879 |
|
|
2021
Q2 | $14.1M | Buy |
+619,384
| New | +$14.1M | ﹤0.01% | 3029 |
|